BUZZ-Imricor Medical Systems rises on US FDA clearance for two devices

** Shares of ASX-listed Imricor Medical Systems IMR.AX rise as much as 16.3% to A$2.1, their highest level since late April

** U.S.-headquartered medical equipment maker gets Food and Drug Administration nod for its NorthStar mapping system and Vision-MR diagnostic catheter for pediatric label expansion

** The approval would allow co to market the two products for use with patients of any age, including children and young adults

** Stock up over 30% YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.